Scarica l'app Stockscreener
2.90
0.68%
-0.02
Dopo l'orario di chiusura:
2.90
Xeris Biopharma Holdings Inc Borsa (XERS) Ultime notizie
Analysts Expect Breakeven For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Before Long - Yahoo Finance
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): When Will It Breakeven? - Simply Wall St
HC Wainwright Forecasts Reduced Earnings for Xeris Biopharma - Defense World
Wealth Enhancement Advisory Services LLC Invests $35,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
FY2024 EPS Estimate for Xeris Biopharma Raised by Analyst - Defense World
HC Wainwright Forecasts Higher Earnings for Xeris Biopharma - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Rating Lowered to Neutral at Piper Sandler - Defense World
Xeris Biopharma (NASDAQ:XERS) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
HC Wainwright Forecasts Weaker Earnings for Xeris Biopharma - MarketBeat
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Xeris Biopharma posts record revenue in Q3 2024 - Investing.com India
Earnings call: Xeris Biopharma posts record revenue in Q3 2024 By Investing.com - Investing.com Nigeria
Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highli - GuruFocus.com
Xeris Biopharma Holdings Inc (XERS) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Xeris Biopharma Reports Record Third Quarter Revenue - TipRanks
Xeris Biopharma Holdings Inc (XERS) Quarterly 10-Q Report - Quartzy
Xeris raises revenue outlook on strong 3rd-quarter results - Crain's Chicago Business
Xeris Biopharma Reports Third Quarter 2024 Financial Results - BioSpace
Xeris Biopharma (XERS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Xeris Biopharma (XERS) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Xeris Biopharma Holdings Inc Reports Q3 2024 Revenue of $54.3M, Beating Estimates; EPS Misses at ($0.11) - GuruFocus.com
Xeris Biopharma: Q3 Earnings Snapshot - San Francisco Chronicle
Xeris Biopharma (XERS) to Release Earnings on Friday - Defense World
Xeris Biopharma (XERS) Scheduled to Post Quarterly Earnings on Friday - MarketBeat
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - BioSpace
Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha
SG Americas Securities LLC Raises Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
The Manufacturers Life Insurance Company Buys 5,291 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
The Xeris Biopharma Holdings Inc (XERS) had a good session last reading, didn’t it? - US Post News
Dimensional Fund Advisors LP Sells 6,437 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Xeris Biopharma Holdings Inc (XERS) looking to reclaim success with recent performance - SETE News
Market Recap Check: Xeris Biopharma Holdings Inc (XERS)’s Positive Finish at 2.97, Up/Down 2.06 - The Dwinnex
Xeris Biopharma Holdings Inc [XERS] Insider Activity: An Update for Investors - Knox Daily
Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips + - Seeking Alpha
Xeris Biopharma Holdings Inc [NASDAQ: XERS] Sees Decrease in Stock Value - Knox Daily
Ratio Review: Analyzing Xeris Biopharma Holdings Inc (XERS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Charting the Course: Xeris Biopharma Holdings Inc’s XERS Stock Prospects - The InvestChronicle
Several Insiders Invested In Xeris Biopharma Holdings Flagging Positive News - Yahoo Finance
Xeris Biopharma: Time For A Reassessment (NASDAQ:XERS) - Seeking Alpha
This trade activity should not be overlooked: Xeris Biopharma Holdings Inc (XERS) - SETE News
A year in review: Xeris Biopharma Holdings Inc (XERS)’s performance in the last year - US Post News
Xeris Biopharma Holdings Inc (XERS) Becoming More Attractive for Investors - Knox Daily
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
XERS Shares Experience Surge in Value - Knox Daily
XTX Topco Ltd Sells 223,267 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
XTX Topco Ltd Cuts Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat
Renaissance Technologies LLC Acquires 342,300 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Perhaps timely catching Xeris Biopharma Holdings Inc (XERS) would be a good idea - SETE News
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Rhumbline Advisers Raises Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
Does Xeris Biopharma Holdings Inc (XERS) offer a good opportunity for investors? - SETE News
A company insider recently bought 4,515 shares of Xeris Biopharma Holdings Inc [XERS]. Should You Buy? - Knox Daily
Xeris Biopharma Holdings Inc (XERS) presents a great opportunity, but the stock is slightly overvalued - US Post News
A Guide To The Risks Of Investing In Xeris Biopharma Holdings Inc (XERS) - Knox Daily
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Bought by Bank of New York Mellon Corp - Defense World
Asset Management Group Inc. Acquires 15,000 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):